Details

Autor(en) / Beteiligte

• Siratavičiūtė, Vitalija
• Pangonytė, Dalia
• Utkienė, Lina
• Jusienė, Lina
• Marcinkevičienė, Jolanta
• Stanionienė, Zita
• Radikė, Reda

Titel

Myocardial Angiotensin-Converting Enzyme 2 Protein Expression in Ischemic Heart Failure

Ist Teil von

• International journal of molecular sciences, 2023-12, Vol.24 (24), p.17145

Ort / Verlag

Switzerland: MDPI AG

Erscheinungsjahr

2023

Link zum Volltext

Quelle

EZB Electronic Journals Library

Beschreibungen/Notizen

• The angiotensin-converting enzyme 2 (ACE2)-angiotensin-(1-7)-Mas receptor axis plays a significant role in regulating myocardial remodeling and the development of heart failure (HF), with ACE2 being the primary focus. However, contemporary understanding of the membrane-bound form of the human ACE2 protein remains insufficient. The purpose of this study was to determine the expression of ACE2 protein in different cells of the left ventricular myocardium in non-diseased hearts and at various stages of ischemic HF. A total of 103 myocardial tissue samples from the left ventricle underwent quantitative and semi-quantitative immunohistochemical analysis. Upon assessing ACE2 immunostaining in all myocardial cells through unselective digital image analysis, there was no change in the stage A HF group. Nevertheless, the expression of ACE2 membrane protein in cardiomyocytes showed a tendency to increase, while non-cardiomyocyte ACE2 expression decreased significantly ( < 0.001). In the stage B HF group, the intensity of ACE2 immunostaining continued to increase with rising cardiomyocyte ACE2 expression ( < 0.001). Non-cardiomyocyte expression, in contrast, remained similar to that observed in the stage A HF group. In the stages C/D HF group, ACE2 expression reached its highest level in cardiomyocytes ( < 0.001), while ACE2 expression in non-cardiomyocytes was the lowest ( < 0.001). These changes in ACE2 protein levels are associated with left ventricular remodeling in ischemic HF.